Commercial weight loss programs have long been a popular option for those looking to shed a few pounds or manage their weight, but recently, they’ve evolved dramatically—parti ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...